Dual Thrusts for Idera Pharmaceuticals Inc. (IDRA) Stock
It takes a domain expert to appreciate this stock, but that does not dilute any true value. This Biotechnology & Drugs Industry small-capital stock is from Cambridge, MA. The geographical base itself should arouse investor curiosity because this part of the United States has an enviable record of creating future business winners. The current financial parameters of the stock are so negative that even the most patient investor may look at it askance. The Beta is 1.61 and the company has lost $0.40 per share during the last financial period. 22.95 shares are on offer, but knowledgeable institutions have picked…